Industry News
ResMed quarterly profit grows 3%
ResMed (ASX:RMD) has reported its results for its fiscal first quarter and has unveiled new and improved patient management platforms for its sleep-disordered breathing treatment devices.
[ + ]Alchemia CSO wins Telstra businesswoman award
Alchemia (ASX:ACL) Chief Scientific Officer Dr Tracey Brown has won the Telstra Victorian Business Woman of the Year award and is now eligible to win the national award as well.
[ + ]ANSTO researcher receives WiN Global Award
The annual Women in Nuclear (WiN) Global Award has been won by Dr Margaret Elcombe of the Australian Nuclear Science and Technology Organisation (ANSTO) - the first Australian ever to receive the award. [ + ]
Auspherix gets $1m in financing
The Medical Research Commercialisation Fund has granted $1m in financing to early-stage anti-infectives company Auspherix.
[ + ]Commonwealth makes IP data available online
In a world first, the Australian Government has announced it will make 100 years of intellectual property (IP) rights data available online in order to make finding collaboration partners easier and allow the mapping of innovation.
[ + ]Over $500m for medical research
The Australian Government has allocated $580.2 million to help Australian health and medical researchers find the cures, treatments and medical devices of the future. [ + ]
Clinical Genomics, CSIRO settle on licence terms
Clinical Genomics and the CSIRO have signed an international licensing agreement covering their jointly developed blood test for bowel cancer.
[ + ]Over $500m for NHMRC grants
The Australian Government has allocated $580.2 million to fund 848 National Health and Medical Research Council (NHMRC) grants.
[ + ]AusBiotech tells inquiry why 1.5% cut is not benign for biotech
AusBiotech said in its submission to the Inquiry into the 'Tax and Superannuation Laws Amendment (2014 Measures No 5) Bill 2014' that the seemingly small but not benign change, announced in the May 2014 Federal Budget, will permanently impact companies in tax loss.
[ + ]Anatara preps manufacturing for Detach trial
Anatara Lifesciences is taking steps towards registration with the AVPMA for non-antibiotic diarrhoea treatment Detach, initiating the manufacturing process for Australian trials in pigs.
[ + ]ATSE elects 2014 Fellows
The Australian Academy of Technological Sciences and Engineering (ATSE) has elected 25 new Fellows for 2014. The academy is an independent body of 800 eminent scientists and engineers seeking to enhance Australia's prosperity through technological innovation.
[ + ]Koala transcriptome revealed
A blueprint for the koala genome has been sequenced, with researchers transcribing 15,000 koala genes.
[ + ]Link between viral infection and autoimmune disease
Australian scientists have discovered that common viral infections can pave the way to autoimmune disease. [ + ]
Ramaciotti Foundations award $1m for biomedical research
The Clive and Vera Ramaciotti Foundations are awarding $1,022,458 to biomedical research through the distribution of the annual Ramaciotti Medal for Excellence in Biomedical Research and 13 establishment grants. [ + ]
Starpharma cancer drug shows good PK profile
Starpharma (ASX:SPL) said preliminary analysis of the pharmacokinetic profile of DEP-docetaxel shows superior duration of exposure compared to the reference drug.
[ + ]